Recruiting at 14 sites Phase 3 COVID-19 Vaccines

COVID-19 Vaccines study: BNT162b2

Official title A Study of COVID-19 Vaccine(s) in Children and Adults

ClinicalTrials.gov ID: NCT07798648

What this study is testing

What is BNT162b2?

an investigational COVID-19 vaccine being studied for safety and effects against the 2026/2027 recommended strain is designed to deliver mRNA that instructs cells to produce the SARS‑CoV‑2 spike protein, prompting an immune response

Plain-language explanation of the investigational treatment. It is being studied and is not an approved or proven therapy. The study team can confirm the details.

What it's testing
The study aims to find out how safe the updated vaccine is and what side effects it may cause in these age groups.
Who it's for
People 5‑64 years old with at least one health condition that raises COVID‑19 risk, and anyone 65 years or older, who are medically stable and haven’t had a recent COVID infection or vaccine.
What's involved
Participants get a single injection of the vaccine (dose depends on age) and may be told which version they receive or not, depending on the group. They will attend at least three clinic visits, give nose swabs and blood samples, and record any side effects in a diary.
Time commitment
The study lasts about six months with a minimum of three study visits.
  • Phase 3: a large, late-stage study
  • Time commitment: about 6 months

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 5 and older. Healthy volunteers may be eligible.

You may be able to join if

  • Participants 5 years of age or older.
  • Participants 5 through 64 years of age should have at least 1 underlying medical condition that increases their risk of severe COVID-19. Key

You likely can't join if

  • History of severe adverse reaction associated with a vaccine and/or severe allergic reaction (eg, anaphylaxis) to any component of the study...
  • History of myocarditis or pericarditis.
  • Receipt of a COVID-19 vaccine or a confirmed case of COVID-19 (confirmed by signs/symptoms and/or a positive test result based on local testing) less...

The study team makes the final eligibility decision.

Where it is enrolling

  • Homestead, Florida, United States
  • Miami Lakes, Florida, United States
  • Atlanta, Georgia, United States
  • Honolulu, Hawaii, United States
  • Bardstown, Kentucky, United States
  • Dayton, Ohio, United States
  • South Euclid, Ohio, United States
  • Philadelphia, Pennsylvania, United States
  • Dallas, Texas, United States
  • Euless, Texas, United States
  • Houston, Texas, United States
  • Tomball, Texas, United States
  • Salt Lake City, Utah, United States

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.

How long does this study last?

The study runs about 6 months per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.

Who can join this trial?

This study is enrolling all sexes, 5 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.

Where is this trial taking place?

This study is enrolling now at Homestead, Florida, United States; Miami Lakes, Florida, United States; Atlanta, Georgia, United States; Honolulu, Hawaii, United States; Bardstown, Kentucky, United States; Dayton, Ohio, United States and 7 more locations. Enter your location above to see the nearest enrolling site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.